Synovics Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004
Period Ending	Jul '09 Jul 31, 2009	Oct '08 Oct 31, 2008	Oct '07 Oct 31, 2007	Oct '06 Oct 31, 2006	Oct '05 Oct 31, 2005	Oct '04 Oct 31, 2004
Cash & Equivalents	0.13	0.07	-	2.39	0.13	0.63
Cash & Short-Term Investments	0.13	0.07	-	2.39	0.13	0.63
Cash Growth	-69.52%	-	-	1757.98%	-79.53%	19857.41%
Receivables	1.54	3.82	3.33	2.04	-	-
Inventory	2.32	2.9	1.93	2.38	0	0.05
Prepaid Expenses	0.68	0.38	0.3	0.92	0.14	0.02
Total Current Assets	4.68	7.17	5.56	7.73	0.27	0.7
Property, Plant & Equipment	2.2	2.48	2.02	1.64	0	0
Long-Term Investments	-	-	-	-	1.23	1.45
Goodwill	11.45	11.45	11.45	11.45	-	-
Other Intangible Assets	0.34	0.46	1.32	15.71	14.6	0.72
Long-Term Deferred Charges	0.02	0.7	2.9	1.97	0.38	-
Other Long-Term Assets	0.09	0.09	0.09	0.38	0.43	-
Total Assets	18.77	22.35	23.33	38.88	16.91	2.88
Accounts Payable	7.54	5.98	4.72	3.23	1.01	1.58
Accrued Expenses	4.81	4.43	7.07	3.71	1.72	0.72
Short-Term Debt	1.65	0.54	8.48	-	1.45	1.48
Current Portion of Long-Term Debt	2.4	2.1	4.7	6.09	1.42	-
Current Portion of Leases	0.11	0.07	0.05	-	-	-
Other Current Liabilities	1.04	0.38	-	-	-	-
Total Current Liabilities	17.55	13.5	25.02	13.02	5.61	3.78
Long-Term Debt	1.7	3.55	5.45	11.5	-	-
Long-Term Leases	0.29	0.29	0.12	0.28	-	-
Long-Term Unearned Revenue	-	-	0.85	0.98	-	-
Total Liabilities	19.54	17.34	31.44	25.78	5.61	3.78
Common Stock	0.04	0.04	0.03	0.03	0.02	0.02
Additional Paid-In Capital	85.37	84.76	71.54	61.88	54.8	39.8
Retained Earnings	-85.03	-78.65	-74.26	-53.4	-44.83	-41.92
Treasury Stock	-10.95	-10.95	-10.95	-0.18	-	-
Comprehensive Income & Other	8.98	8.98	4.74	3.99	0.51	0.4
Total Common Equity	-1.6	4.17	-8.9	12.3	10.5	-1.7
Shareholders' Equity	-0.77	5	-8.1	13.1	11.3	-0.9
Total Liabilities & Equity	18.77	22.35	23.33	38.88	16.91	2.88
Total Debt	6.15	6.55	18.8	17.87	2.88	1.48
Net Cash (Debt)	-6.02	-6.49	-18.8	-15.47	-2.75	-0.85
Net Cash Per Share	-0.22	-0.28	-0.99	-0.59	-0.14	-0.11
Filing Date Shares Outstanding	29.83	29.83	19.12	26.04	22.68	16.05
Total Common Shares Outstanding	28.94	27.62	19.12	25.99	22.68	16
Working Capital	-12.87	-6.34	-19.46	-5.29	-5.34	-3.08
Book Value Per Share	-0.06	0.15	-0.47	0.47	0.46	-0.11
Tangible Book Value	-13.39	-7.74	-21.67	-14.86	-4.1	-2.43
Tangible Book Value Per Share	-0.46	-0.28	-1.13	-0.57	-0.18	-0.15
Buildings	-	-	-	-	-	0.07
Machinery	-	2.74	2.1	1.55	0.08	-
Leasehold Improvements	-	0.66	0.42	0.26	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.